About this trial
Thoracic aneurysm is a silent disease with a potential mid-term high risk of death or major complications. Few data are available on the real incidence of major complications in case of small and moderate thoracic aneurysm. Different factors are supposed to increase the risk of aortic enlargement as high blood pressure and sleep disorder breathing. The modality of imaging and clinical follow-up are well defined. In this prospective observational study, the aim to assess the incidence of of major complications during follow-up in a population of patients with a small or moderate thoracic aneurysm. The study will also try to identify systemic factors influencing aneurysm evolution.
Eligibility criteria
Qualifiers
Documentation of an aortic root aneurysm > 40 mm
Agreement to participate to a longitudinal study and available for a 5 years follow-up
Disqualifiers
Presence of comorbidities or pathology with a prognosis of less than 1 year
Personal or family history of genetically documented elastic tissue disease or patient meeting the GAND clinical criteria suggestive of Marfan disease
High-grade mitra-aortic valve disease, even if asymptomatic
Unbalanced hypertension ≥ 180/110 mmHg
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University Hospital, Lille
Lead sponsor
Santelys Association
Collaborator
Région Nord-Pas de Calais, France
Collaborator
Association de Cardiologie Nord-Pas de Calais
Collaborator